Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study - Gonzalez, Ana Lopez; Del Barco Berron, Sonia; Grau, Isabel; Galan, Maria; Castelo Fernandez, Beatriz; Cortes, Alfonso; Sanchez Rovira, Pedro; Martinez-Bueno, Alejandro; Gonzalez, Xavier; Garcia, Almudena; Gener, Petra; Mina, Leonardo; et al. (Cancers, 2022)